| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |